Document is current
Any future updates will be listed below
-
Authors
Franzen, Anna
Loof, Jesper
Birgersson, Ulrik
Kiselovs, Glebs
Pokosta, Maria
Engqvist, Hakan
-
Funding
Funding for this research was provided by:
Emplicure AB
- License Information
-
More Information
Article History
Received: 3 February 2025
Accepted: 5 July 2025
First Online: 18 July 2025
Declarations
:
: The clinical study protocol, the subject information and the informed consent form was approved by the Swedish ethical review authority. The study was conducted in the accordance with the ethical principles from the Declaration of Helsinki, International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) Good Clinical Practice (GCP) E6 (R2) guidance, applicable parts of the European Union (EU) Clinical Trials Directive 2001/20/EC, and applicable local regulatory requirements. All subjects signed informed consent to participate in the study.
: All subjects signed informed consent that the data from the study can be published in scientific journals.
: All authors are employed or consultants of Emplicure AB. AE, JL, GK, MP and HE have financial interest in Emplicure.
